Bills Introduced in March: Importation, Cancer Drugs and PBM Transparency
By Zachary Brennan -
Published 17 March 2017
At least nine US House and Senate bills introduced in March would impact the pharmaceutical industry, including three to allow for more prescription drug imports from Canada, pharmacy benefit management (PBM) transparency and one on cost sharing for cancer medicines.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Government affairs
Tags: Cummings, Sanders, drug prices, PBMs